Market Closed -
Nyse
04:00:02 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
46.7
USD
|
-0.11%
|
|
-5.56%
|
-22.45%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,025
|
12,920
|
14,405
|
22,805
|
17,201
|
13,339
|
-
|
-
|
Enterprise Value (EV)
1 |
7,748
|
12,094
|
15,529
|
22,805
|
16,235
|
17,097
|
16,086
|
16,432
|
P/E ratio
|
25.2
x
|
77.9
x
|
24.6
x
|
5.84
x
|
8.54
x
|
9.74
x
|
7.22
x
|
5.31
x
|
Yield
|
4.57%
|
1.65%
|
2.57%
|
-
|
-
|
5.18%
|
5.99%
|
9.26%
|
Capitalization / Revenue
|
3.61
x
|
7.11
x
|
5.03
x
|
2.13
x
|
2.3
x
|
2.53
x
|
2.03
x
|
1.83
x
|
EV / Revenue
|
3.99
x
|
6.66
x
|
5.43
x
|
2.13
x
|
2.17
x
|
3.25
x
|
2.45
x
|
2.25
x
|
EV / EBITDA
|
12
x
|
20.9
x
|
13.1
x
|
3.91
x
|
5.11
x
|
8.21
x
|
5.51
x
|
4.61
x
|
EV / FCF
|
73.3
x
|
-714
x
|
43.4
x
|
7.19
x
|
-12.7
x
|
16.9
x
|
14
x
|
8.92
x
|
FCF Yield
|
1.36%
|
-0.14%
|
2.3%
|
13.9%
|
-7.9%
|
5.92%
|
7.16%
|
11.2%
|
Price to Book
|
3.37
x
|
6.09
x
|
4.53
x
|
4.66
x
|
3.11
x
|
2.41
x
|
2.29
x
|
1.47
x
|
Nbr of stocks (in thousands)
|
263,197
|
263,197
|
285,638
|
285,638
|
285,638
|
285,638
|
-
|
-
|
Reference price
2 |
26.69
|
49.09
|
50.43
|
79.84
|
60.22
|
46.70
|
46.70
|
46.70
|
Announcement Date
|
3/3/20
|
3/4/21
|
3/3/22
|
3/3/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,944
|
1,817
|
2,862
|
10,711
|
7,468
|
5,263
|
6,570
|
7,299
|
EBITDA
1 |
645.1
|
579.8
|
1,186
|
5,838
|
3,180
|
2,081
|
2,920
|
3,565
|
EBIT
1 |
442.9
|
375.9
|
971.3
|
5,242
|
2,899
|
1,909
|
2,704
|
3,223
|
Operating Margin
|
22.79%
|
20.68%
|
33.93%
|
48.94%
|
38.83%
|
36.27%
|
41.15%
|
44.16%
|
Earnings before Tax (EBT)
1 |
390.6
|
238.5
|
841.2
|
5,486
|
2,807
|
1,570
|
2,507
|
3,214
|
Net income
1 |
278.1
|
164.5
|
585.5
|
3,906
|
2,013
|
1,370
|
1,849
|
2,241
|
Net margin
|
14.31%
|
9.05%
|
20.46%
|
36.47%
|
26.95%
|
26.03%
|
28.14%
|
30.71%
|
EPS
2 |
1.060
|
0.6300
|
2.050
|
13.68
|
7.050
|
4.795
|
6.468
|
8.791
|
Free Cash Flow
1 |
105.6
|
-16.95
|
357.8
|
3,172
|
-1,282
|
1,012
|
1,152
|
1,843
|
FCF margin
|
5.44%
|
-0.93%
|
12.5%
|
29.62%
|
-17.17%
|
19.22%
|
17.54%
|
25.25%
|
FCF Conversion (EBITDA)
|
16.38%
|
-
|
30.18%
|
54.34%
|
-
|
48.61%
|
39.45%
|
51.69%
|
FCF Conversion (Net income)
|
37.99%
|
-
|
61.11%
|
81.21%
|
-
|
73.84%
|
62.32%
|
82.21%
|
Dividend per Share
2 |
1.220
|
0.8100
|
1.299
|
-
|
-
|
2.420
|
2.800
|
4.323
|
Announcement Date
|
3/3/20
|
3/4/21
|
3/3/22
|
3/3/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1,084
|
2,020
|
2,599
|
2,958
|
3,134
|
2,264
|
2,052
|
1,840
|
1,312
|
1,084
|
1,209
|
1,266
|
1,445
|
1,701
|
1,789
|
EBITDA
1 |
559.5
|
1,186
|
1,324
|
1,660
|
1,667
|
1,088
|
876.5
|
788.2
|
427.6
|
403.6
|
443.5
|
485.7
|
629.8
|
677.1
|
719.5
|
EBIT
1 |
507.8
|
1,131
|
1,264
|
1,597
|
1,540
|
1,024
|
809.9
|
713.5
|
351.7
|
330.2
|
387.4
|
431.4
|
530
|
605.8
|
635.7
|
Operating Margin
|
46.83%
|
56.01%
|
48.63%
|
53.99%
|
49.13%
|
45.24%
|
39.47%
|
38.77%
|
26.81%
|
30.45%
|
32.05%
|
34.08%
|
36.67%
|
35.61%
|
35.53%
|
Earnings before Tax (EBT)
1 |
466.1
|
1,111
|
1,216
|
1,554
|
1,605
|
1,033
|
802.1
|
697.6
|
273.8
|
300.2
|
339.6
|
456.2
|
495.6
|
579
|
605
|
Net income
1 |
321.6
|
796.1
|
859.3
|
1,100
|
1,151
|
749.9
|
580.3
|
479.3
|
203.2
|
-869.5
|
235.9
|
316.7
|
343.8
|
401.4
|
419
|
Net margin
|
29.66%
|
39.42%
|
33.07%
|
37.18%
|
36.73%
|
33.12%
|
28.28%
|
26.04%
|
15.49%
|
-80.18%
|
19.52%
|
25.01%
|
23.79%
|
23.6%
|
23.42%
|
EPS
2 |
1.130
|
2.790
|
3.008
|
3.850
|
4.030
|
2.630
|
2.030
|
1.670
|
0.7100
|
-3.040
|
0.8257
|
1.109
|
-
|
1.405
|
1.467
|
Dividend per Share
2 |
0.1938
|
-
|
1.849
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.2134
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/3/22
|
5/19/22
|
8/17/22
|
11/17/22
|
3/3/23
|
5/18/23
|
8/17/23
|
11/16/23
|
2/28/24
|
5/23/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
724
|
-
|
1,124
|
-
|
-
|
3,757
|
2,747
|
3,092
|
Net Cash position
1 |
-
|
826
|
-
|
-
|
966
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.122
x
|
-
|
0.9481
x
|
-
|
-
|
1.805
x
|
0.9405
x
|
0.8675
x
|
Free Cash Flow
1 |
106
|
-16.9
|
358
|
3,172
|
-1,282
|
1,012
|
1,152
|
1,843
|
ROE (net income / shareholders' equity)
|
13.3%
|
7.82%
|
22.1%
|
96.7%
|
38.6%
|
28.3%
|
29.3%
|
33%
|
ROA (Net income/ Total Assets)
|
6.21%
|
3.46%
|
9.87%
|
43.4%
|
17.9%
|
10%
|
14.1%
|
20.5%
|
Assets
1 |
4,476
|
4,751
|
5,932
|
9,000
|
11,262
|
13,700
|
13,069
|
10,921
|
Book Value Per Share
2 |
7.930
|
8.070
|
11.10
|
17.10
|
19.40
|
19.40
|
20.40
|
31.70
|
Cash Flow per Share
2 |
1.620
|
0.6900
|
2.880
|
14.30
|
-0.6200
|
6.280
|
6.570
|
10.50
|
Capex
1 |
321
|
322
|
465
|
905
|
1,104
|
1,371
|
1,065
|
806
|
Capex / Sales
|
16.53%
|
17.73%
|
16.24%
|
8.45%
|
14.78%
|
26.04%
|
16.2%
|
11.04%
|
Announcement Date
|
3/3/20
|
3/4/21
|
3/3/22
|
3/3/23
|
2/28/24
|
-
|
-
|
-
|
Last Close Price
46.7
USD Average target price
66.81
USD Spread / Average Target +43.07% Consensus |
1st Jan change
|
Capi.
|
---|
| -22.45% | 13.34B | | +17.07% | 66.31B | | -0.29% | 48.46B | | +21.61% | 43.27B | | +27.29% | 27.41B | | +9.25% | 19.26B | | -2.14% | 16.61B | | +9.75% | 16.58B | | -15.01% | 14.41B | | -30.22% | 14.02B |
Other Specialty Chemicals
|